An immunosuppressant, FK506, protects against neuronal dysfunction and death but has no effect on electrographic and behavioral activities induced by systemic kainate

A. Moriwaki, Y. F. Lu, Kazuhito Tomizawa, Hideki Matsui

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Kainate is a potent agonist of an excitatory amino acid receptor subtype in the central nervous system, and muses neuronal death in several regions of the brain. Neurons are preferentially killed in the hippocampus, especially in the CA1 region, by systemic administration of kainate. It is speculated that functional alterations occur in the neurons preceding death. We examined the effect of FK506 on kainate-induced neuronal death and functional alterations in the rat hippocampal CA1 region. FK506 had no effect on electrographic and behavioral seizure activities induced by kainate; however, it prevented neuronal death measured seven days after administration. Although neither death nor morphological alterations of neurons were observed in the CA1 region 24 h after administration, the neurons exhibited decreased excitatory postsynaptic potentials and enhanced long-term potentiation. This functional alteration was not detected in the rats administered FK506 prior to kainate. Taken together, these observations indicate that functional alteration precedes neuronal death in rats systemically administered kainate and that FK506 prevents both. It is suggested that FK506 exerts its neuroprotective effect not by attenuating electrographic and behavioral seizure activities, but by protecting neurons from kainate-induced functional disorders.

Original languageEnglish
Pages (from-to)855-865
Number of pages11
JournalNeuroscience
Volume86
Issue number3
DOIs
Publication statusPublished - Jun 8 1998

Fingerprint

Kainic Acid
Tacrolimus
Immunosuppressive Agents
Neurons
Seizures
Hippocampal CA1 Region
Long-Term Potentiation
Alprostadil
Excitatory Postsynaptic Potentials
Glutamate Receptors
Neuroprotective Agents
Hippocampus
Central Nervous System
Brain

Keywords

  • Cell death
  • Fiber volley
  • FK506
  • Hippocampus
  • Kainate
  • Long-term potentiation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

An immunosuppressant, FK506, protects against neuronal dysfunction and death but has no effect on electrographic and behavioral activities induced by systemic kainate. / Moriwaki, A.; Lu, Y. F.; Tomizawa, Kazuhito; Matsui, Hideki.

In: Neuroscience, Vol. 86, No. 3, 08.06.1998, p. 855-865.

Research output: Contribution to journalArticle

@article{0803a0dec44e40cf9f5f3cbafbb8ab72,
title = "An immunosuppressant, FK506, protects against neuronal dysfunction and death but has no effect on electrographic and behavioral activities induced by systemic kainate",
abstract = "Kainate is a potent agonist of an excitatory amino acid receptor subtype in the central nervous system, and muses neuronal death in several regions of the brain. Neurons are preferentially killed in the hippocampus, especially in the CA1 region, by systemic administration of kainate. It is speculated that functional alterations occur in the neurons preceding death. We examined the effect of FK506 on kainate-induced neuronal death and functional alterations in the rat hippocampal CA1 region. FK506 had no effect on electrographic and behavioral seizure activities induced by kainate; however, it prevented neuronal death measured seven days after administration. Although neither death nor morphological alterations of neurons were observed in the CA1 region 24 h after administration, the neurons exhibited decreased excitatory postsynaptic potentials and enhanced long-term potentiation. This functional alteration was not detected in the rats administered FK506 prior to kainate. Taken together, these observations indicate that functional alteration precedes neuronal death in rats systemically administered kainate and that FK506 prevents both. It is suggested that FK506 exerts its neuroprotective effect not by attenuating electrographic and behavioral seizure activities, but by protecting neurons from kainate-induced functional disorders.",
keywords = "Cell death, Fiber volley, FK506, Hippocampus, Kainate, Long-term potentiation",
author = "A. Moriwaki and Lu, {Y. F.} and Kazuhito Tomizawa and Hideki Matsui",
year = "1998",
month = "6",
day = "8",
doi = "10.1016/S0306-4522(98)00071-2",
language = "English",
volume = "86",
pages = "855--865",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - An immunosuppressant, FK506, protects against neuronal dysfunction and death but has no effect on electrographic and behavioral activities induced by systemic kainate

AU - Moriwaki, A.

AU - Lu, Y. F.

AU - Tomizawa, Kazuhito

AU - Matsui, Hideki

PY - 1998/6/8

Y1 - 1998/6/8

N2 - Kainate is a potent agonist of an excitatory amino acid receptor subtype in the central nervous system, and muses neuronal death in several regions of the brain. Neurons are preferentially killed in the hippocampus, especially in the CA1 region, by systemic administration of kainate. It is speculated that functional alterations occur in the neurons preceding death. We examined the effect of FK506 on kainate-induced neuronal death and functional alterations in the rat hippocampal CA1 region. FK506 had no effect on electrographic and behavioral seizure activities induced by kainate; however, it prevented neuronal death measured seven days after administration. Although neither death nor morphological alterations of neurons were observed in the CA1 region 24 h after administration, the neurons exhibited decreased excitatory postsynaptic potentials and enhanced long-term potentiation. This functional alteration was not detected in the rats administered FK506 prior to kainate. Taken together, these observations indicate that functional alteration precedes neuronal death in rats systemically administered kainate and that FK506 prevents both. It is suggested that FK506 exerts its neuroprotective effect not by attenuating electrographic and behavioral seizure activities, but by protecting neurons from kainate-induced functional disorders.

AB - Kainate is a potent agonist of an excitatory amino acid receptor subtype in the central nervous system, and muses neuronal death in several regions of the brain. Neurons are preferentially killed in the hippocampus, especially in the CA1 region, by systemic administration of kainate. It is speculated that functional alterations occur in the neurons preceding death. We examined the effect of FK506 on kainate-induced neuronal death and functional alterations in the rat hippocampal CA1 region. FK506 had no effect on electrographic and behavioral seizure activities induced by kainate; however, it prevented neuronal death measured seven days after administration. Although neither death nor morphological alterations of neurons were observed in the CA1 region 24 h after administration, the neurons exhibited decreased excitatory postsynaptic potentials and enhanced long-term potentiation. This functional alteration was not detected in the rats administered FK506 prior to kainate. Taken together, these observations indicate that functional alteration precedes neuronal death in rats systemically administered kainate and that FK506 prevents both. It is suggested that FK506 exerts its neuroprotective effect not by attenuating electrographic and behavioral seizure activities, but by protecting neurons from kainate-induced functional disorders.

KW - Cell death

KW - Fiber volley

KW - FK506

KW - Hippocampus

KW - Kainate

KW - Long-term potentiation

UR - http://www.scopus.com/inward/record.url?scp=0031836346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031836346&partnerID=8YFLogxK

U2 - 10.1016/S0306-4522(98)00071-2

DO - 10.1016/S0306-4522(98)00071-2

M3 - Article

C2 - 9692722

AN - SCOPUS:0031836346

VL - 86

SP - 855

EP - 865

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 3

ER -